LUCAS ROGER C 4
4 · BIO-TECHNE Corp · Filed Oct 12, 2017
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
LUCAS ROGER C
Director
Transactions
- Sale
Common Stock
2017-10-10$121.95/sh−100$12,196→ 1,870 total
Holdings
- 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 3,985
Stock Option (right to buy)
Exercise: $101.19Exp: 2026-10-26→ Common Stock (3,985 underlying) - 4,000
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016.
- [F2]The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.